Related references
Note: Only part of the references are listed.Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104
Fan Li et al.
ONCOGENE (2020)
Structural basis of GPBAR activation and bile acid recognition
Fan Yang et al.
NATURE (2020)
Animal models to study bile acid metabolism
Jianing Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium
Yun-Fei Xu et al.
ONCOGENE (2019)
Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway
Rongqi Sun et al.
EBIOMEDICINE (2019)
FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma
Lixia Gao et al.
ONCOGENE (2019)
Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle
Bo Qiu et al.
EBIOMEDICINE (2019)
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
Lipika Goyal et al.
CANCER DISCOVERY (2017)
Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression
Yunfei Xu et al.
ONCOTARGET (2017)
Gastrointestinal Complications of Obesity
Michael Camilleri et al.
GASTROENTEROLOGY (2017)
Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival
Timur Mitin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study
Sharayu Mhatre et al.
LANCET ONCOLOGY (2017)
New Horizons for Precision Medicine in Biliary Tract Cancers
Juan W. Valle et al.
CANCER DISCOVERY (2017)
Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival
Timur Mitin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Biliary Cancer: Utility of Next-Generation Sequencing for Clinical Management
Milind Javle et al.
CANCER (2016)
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes
David P. Sonne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
Kai Hung Tiong et al.
ONCOTARGET (2016)
Gallbladder Cancer Incidence and Mortality, United States 1999-2011
S. Jane Henley et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
Margit Hagel et al.
CANCER DISCOVERY (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2014)
Fibroblast growth factor receptor 4 promotes progression and correlates Cross Mark to poor prognosis in cholangiocarcinoma
Yun-Fei Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
Mei Zhou et al.
CANCER RESEARCH (2014)
Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis
Karen Reue et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Christine Heinzle et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Fibroblast Growth Factor Receptor 4 (FGFR4) Deficiency Improves Insulin Resistance and Glucose Metabolism under Diet-induced Obesity Conditions
Hongfei Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
Maolan Li et al.
NATURE GENETICS (2014)
FGF Receptors: Cancer Biology and Therapeutics
Masaru Katoh et al.
MEDICINAL RESEARCH REVIEWS (2014)
TGR5 in cholangiocytes
Verena Keitel et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu et al.
CANCER DISCOVERY (2013)
The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract
Serge J. L. B. Zweers et al.
HEPATOLOGY (2012)
Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression
Yan Wei Ye et al.
CANCER (2011)
Therapeutic utilities of fibroblast growth factor 19
Xinle Wu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Fibroblast Growth Factor Receptor 4 Regulates Tumor Invasion by Coupling Fibroblast Growth Factor Signaling to Extracellular Matrix Degradation
Nami Sugiyama et al.
CANCER RESEARCH (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Bile Acids Activate Fibroblast Growth Factor 19 Signaling in Human Hepatocytes to Inhibit Cholesterol 7 alpha-Hydroxylase Gene Expression
Kwang-Hoon Song et al.
HEPATOLOGY (2009)
High Expression of the Bile Salt-Homeostatic Hormone Fibroblast Growth Factor 19 in the Liver of Patients with Extrahepatic Cholestasis
Frank G. Schaap et al.
HEPATOLOGY (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Identification of a hormonal basis for gallbladder filling
Mihwa Choi et al.
NATURE MEDICINE (2006)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors
M Wiedemann et al.
GENOMICS (2000)
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4
CD Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
